Current status and future perspectives of immunotherapy against urothelial and kidney cancer.

Kobayashi, Takashi; Takeuchi, Ario; Nishiyama, Hiroyuki; Eto, Masatoshi

Kobayashi, Takashi; Takeuchi, Ario; Nishiyama, Hiroyuki; Eto, Masatoshi.

Afiliación

Kobayashi T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Takeuchi A; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Nishiyama H; Department of Urology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Eto M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Jpn J Clin Oncol ; 51(10): 1481-1492, 2021 Oct 05.

Article en En | MEDLINE | ID: mdl-34389866

Asunto(s)

Carcinoma de Células Renales; Neoplasias Renales; Humanos; Inmunoterapia; Neoplasias Renales/tratamiento farmacológico; Nivolumab; Sunitinib

Palabras clave

cancer; immune checkpoint inhibitor; immunotherapy; renal; urothelial

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Jpn J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google